The latest Market Talks covering Equities. Published exclusively on Dow Jones Newswires throughout the day.

2011 ET - Temple & Webster's bull at RBC is concerned that the furniture retailer's margin guidance offers no real clue about FY 2027 revenue expectations. Analyst Wei-Weng Chen says guidance for a FY 2027 Ebitda margin of 5%-6% is extremely ambiguous. Working backwards, he warns clients that the Australian company's guidance allows for revenue growth of 20%, contraction of 17%, and anything in between. Realistically, he thinks the online retailer is expecting revenue to be flat for the period. RBC has a last-published outperform rating on the stock and a target price of 8.00 Australian dollars. Shares are down 15% at A$4.30. (stuart.condie@wsj.com)

1941 ET - Mirvac's share price looks like a good bet to rise after reassuring nervy investors with its FY26 result and outlook, signals Citi. "Given the buy side negativity heading into the results around FY27 earnings guidance, we believe Mirvac's earnings should be received positively," analyst Suraj Nebhani says. Mirvac pointed to FY27 operating EPS of 13.2-13.4 Australian cents. That is up 3% on FY26 at the midpoint of the range and broadly in line with consensus expectations, Citi says. It's underpinned by forecast settlement of 2,800-3,100 residential lots in FY27, with 63% of earnings already secured via pre-sales. "Balance sheet metrics improved significantly, with gearing falling to 24.1%, enabling a newly announced A$200 million buyback," Citi adds. Mirvac ended Tuesday at A$1.74.(david.winning@wsj.com; @dwinningWSJ)

1938 ET - Japanese stocks may fall, tracking Wall Street's losses overnight. U.S. equities' declines come amid a global bond selloff that has sent long-term yields to their highest levels in years. Analysts say the bond rout reflects various factors such as inflation fears spurred by rising energy prices and growing concerns over swelling government deficits. Nikkei futures are 1535 points lower at 66135 on the SGX. The dollar is at 159.57 yen, compared with Y159.73 around Tuesday's Tokyo market close. The Nikkei Stock Average closed 2.5% lower at 67460.73 on Tuesday. (ronnie.harui@wsj.com)

Imaging-tech provider Pro Medicus had a strong FY26 and expressed optimism about the future, but the stock doesn't look cheap to Jefferies. Pro Medicus has signaled increasing levels of wholesale adoption of its Cloud product. It also sees customers opting for all three core products--Viewer, Archive and Worklist--with its cardiology module. "We acknowledge the proven quality of the business, but note that at a share price of circa A$200.00, our analysis suggests the market is assuming Pre Medicus will have a market share of the U.S. PACS-only market of circa 38% by FY35," analyst David Stanton says. That looks aggressive, he adds. Jefferies retains a hold call on Pro Medicus and raises its price target by 4.3% to A$196.40/share. Pro Medicus ended Tuesday at A$196.75. (david.winning@wsj.com; @dwinningWSJ)

Australian homebuilder Mirvac's annual result was better than Jefferies expected. Mirvac pointed to FY27 operating EPS growth of 2.3-3.9%. That would be a solid outcome against a tough backdrop for residential property development, analyst Andrew Dodds says. Mirvac also signaled it would settle 2,800-3,100 residential lots in FY27. That is materially ahead of consensus hopes for 2,347 settlements, Jefferies says. "Gross margins of 23.9% (ex-impaired) are back above the 18-22% target, up from 17.5% in FY25, with all impaired projects now settled," Jefferies adds. It had a hold call and A$1.80/share price target on Mirvac ahead of today's result. Mirvac ended Tuesday at A$1.74. (david.winning@wsj.com; @dwinningWSJ)

1849 ET - Jefferies expects little opposition from investors in plumbing-fittings supplier Reliance Worldwide to the takeover offer from the private equity arm of Brookfield Asset Management. Brookfield is offering A$4.75/share in cash, valuing Reliance's equity at A$3.55 billion. It has raised its offer three times and will now conduct due diligence after Reliance signaled a willingness to support a bid at current levels. Analyst Ramoun Lazar notes Reliance disclosed the offer alongside a cut to expectations for FY27, driven by profit-margin headwinds. "Given another downgrade and little prospect of improvement likely for another 12 months investors are likely to support any formal proposal," Jefferies says. It downgrades Reliance to "hold," from "buy," while raising its price target to be in line with Brookfield's offer. (david.winning@wsj.com; @dwinningWSJ)

1831 ET - Cochlear's opportunities for near-term growth are limited by persistent payer constraints, Jefferies analysts warn. They tell clients in a note they are seeing an increase in prior authorization rejections in U.S. healthcare, which the Australian hearing-implant maker will have to contend with. Higher out-of-pocket costs could lead to delays in higher-priced procedures such as cochlear implants, they warn. The analysts also point to external analysis suggesting that insurers denied between 12% and 18% of U.S. standard prior authorization requests in 2025. They raise their target price 13% to 144.75 Australian dollars, but stay neutral on the stock. Shares are at A$141.20 ahead of the open. (stuart.condie@wsj.com)

Australian stocks look set to extend their recent losses in early trade, following a soft lead from U.S. equities. ASX futures are down by 0.3% ahead of Wednesday's session, suggesting that the S&P/ASX 200 could be on track for a sixth consecutive loss. The benchmark index is already on its longest losing streak since an eight-session run in April. Ahead of the open, property group Mirvac reported a big rise in annual profit and forecast improved distributions across its current fiscal year. Small-appliance maker Breville reported a 1.7% rise in annual profit, and mineral-sands miner Iluka raised its dividend despite swinging to a first-half loss on weaker prices. (stuart.condie@wsj.com)

1749 ET - Australian advertised salaries grew in July at their fastest annual pace since February 2024, according to employment marketplace Seek. The ASX-listed classifieds group says salaries posted on its domestic platform were up 4.4% on a year earlier, led by a 6.4% jump in education and training positions. Seek says advertised salaries were 0.4% higher than a month earlier, up from the 0.3% growth seen in June and matching the monthly advance seen from January through April. The annual pace exceeds the 3.7% growth in take-home earnings recently seen in data from the Australian Bureau of Statistics. However, the ABS data was for May. (stuart.condie@wsj.com)

1619 ET - AI hiring is expanding beyond traditional technical roles, analysts at LinkedIn's Economic Graph Research Institute say in a research note. The need for people that build AI systems is giving way to hiring for individuals that can deploy, manage and apply those systems, the analysts say. "This suggests AI is becoming a bigger part of everyday work, not just a specialized function," they say. There are also signs of growth in AI leadership roles, albeit unevenly, the analysts say. The share of postings for AI Manager and VP of AI roles has increased in recent years, they say. But the pattern isn't holding for every role -- Head of AI roles have remained stable and Director of AI roles have declined in share, the analysts say. (dean.seal@wsj.com)

1616 ET - The number of AI job postings has roughly doubled in recent years, and those postings carry higher salaries than non-AI roles, though executive-level salaries in the field are retreating, according to analysts at LinkedIn's Economic Graph Research Institute. AI jobs are among the fastest-growing and highest-paying opportunities in the job market right now, with salaries typically around $177,000, compared with $80,000 for non-AI roles, the analysts say. The fastest pay growth has been concentrated in a few roles, including technical staff and forward deployed engineer positions, they say. In contrast, executive positions, such as "Head of AI" or AI Engineer, have remained flat since 2024, and VP of AI roles have seen listed pay decline from highs above $300,000, the analysts say. (dean.seal@wsj.com)

1551 ET - Live cattle futures on the CME snapped a five-session losing streak, closing up 0.2% to $2.1915 a pound. The Tyson beef plant closures and weak cash prices are the "major headwinds" of that streak, says the Hightower Report in a note -- with the firm projecting that "the recent downtrend may have more to run." Lean hog futures sank 2.3% on the day, to 70.825 cents a pound.